HexemBio emerges with a breakthrough blood stem cell rejuvenation technology led by Draper Associates and an advisory ...

MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare ...

HB 334 heads to Gov. Kemp's desk, aiming to align Medicaid coverage for sickle cell and address disparities impacting Black ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can help ...

For patients with heart failure, blood pumps can be lifesaving. But the very forces that sustain circulation can also harm it ...

“I did not hesitate even for a moment,” Kaedi Cecala’s donor, Karol Zwierzinski, tells PEOPLE ...

The attorneys general of Texas and Arizona contend that Cord Blood Registry, which stores umbilical cord cells, profited from ...

Myelofibrosis, a rare bone marrow disorder characterized by fibrosis and impaired blood cell production, requires detailed ...

The American Red Cross partnered with Northwestern Medicine to host the first community blood drive at the recently opened ...

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...